Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study
Objectives To report the 3-year follow-up of a Phase I study of magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) in 30 men with localised prostate cancer. Favourable 12-month safety and ablation precision were previously described. Patients and Methods As a mandated...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
BJU international
Year: 2021, Jahrgang: 127, Heft: 5, Pages: 544-552 |
| ISSN: | 1464-410X |
| DOI: | 10.1111/bju.15268 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/bju.15268 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bju.15268 
|
| Verfasserangaben: | Shiva M. Nair, Gencay Hatiboglu, James Relle, Khalil Hetou, Jason Hafron, Christopher Harle, Zahra Kassam, Robert Staruch, Mathieu Burtnyk, David Bonekamp, Heinz-Peter Schlemmer, Matthias C. Roethke, Maya Mueller-Wolf, Sascha Pahernik and Joseph L. Chin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1896849024 | ||
| 003 | DE-627 | ||
| 005 | 20241205155004.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240729s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bju.15268 |2 doi | |
| 035 | |a (DE-627)1896849024 | ||
| 035 | |a (DE-599)KXP1896849024 | ||
| 035 | |a (OCoLC)1475304931 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Nair, Shiva |e VerfasserIn |0 (DE-588)1337202053 |0 (DE-627)1896848680 |4 aut | |
| 245 | 1 | 0 | |a Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer |b 3-year outcomes of a prospective Phase I study |c Shiva M. Nair, Gencay Hatiboglu, James Relle, Khalil Hetou, Jason Hafron, Christopher Harle, Zahra Kassam, Robert Staruch, Mathieu Burtnyk, David Bonekamp, Heinz-Peter Schlemmer, Matthias C. Roethke, Maya Mueller-Wolf, Sascha Pahernik and Joseph L. Chin |
| 246 | 3 | 3 | |a MRI-guided transurethral ultrasound ablation in patients with localised prostate cancer |
| 264 | 1 | |c 2021 | |
| 300 | |b Illustrationen | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 9. Oktober 2021 | ||
| 500 | |a Gesehen am 29.07.2024 | ||
| 520 | |a Objectives To report the 3-year follow-up of a Phase I study of magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) in 30 men with localised prostate cancer. Favourable 12-month safety and ablation precision were previously described. Patients and Methods As a mandated safety criterion, TULSA was delivered as near whole-gland ablation, applying 3-mm margins sparing 10% of peripheral prostate tissue in 30 men. After 12-month biopsy and MRI, biannual follow-up included prostate-specific antigen (PSA), adverse events (AEs), and functional quality-of-life assessment, with repeat systematic biopsy at 3 years. Results A 3-year follow-up was completed by 22 patients. Between 1 and 3 years, there were no new serious or severe AEs. Urinary and bowel function remained stable. Erectile function recovered by 1 year and was stable at 3 years. The PSA level decreased 95% to a median (interquartile range) nadir of 0.33 (0.1-0.4) ng/mL, stable to 0.8 (0.4-1.6) ng/mL at 3 years. Serial biopsies identified clinically significant disease in 10/29 men (34%) and any cancer in 17/29 (59%). By 3 years, seven men had recurrence (four histological, three biochemical) and had undergone salvage therapy without complications (including six prostatectomies). At 3 years, three of 22 men refused biopsy, and two of the 22 (9%) had clinically significant disease (one new, one persistent). Predictors of salvage therapy requirement included less extensive ablation coverage and higher PSA nadir. Conclusion With 3-year Phase I follow-up, TULSA demonstrates safe and precise ablation for men with localised prostate cancer, providing predictable PSA and biopsy outcomes, without affecting functional abilities or precluding salvage therapy. | ||
| 650 | 4 | |a #PCSM | |
| 650 | 4 | |a #ProstateCancer | |
| 650 | 4 | |a #uroonc | |
| 650 | 4 | |a image-guided intervention | |
| 650 | 4 | |a magnetic resonance imaging | |
| 650 | 4 | |a minimally invasive | |
| 650 | 4 | |a Phase 1 clinical trial | |
| 650 | 4 | |a prostate cancer | |
| 650 | 4 | |a transurethral | |
| 650 | 4 | |a ultrasound ablation | |
| 700 | 1 | |a Hatiboglu, Gencay |d 1979- |e VerfasserIn |0 (DE-588)132495139 |0 (DE-627)522966845 |0 (DE-576)299182673 |4 aut | |
| 700 | 1 | |a Relle, James |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hetou, Khalil |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hafron, Jason |e VerfasserIn |4 aut | |
| 700 | 1 | |a Harle, Christopher |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kassam, Zahra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Staruch, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Burtnyk, Mathieu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bonekamp, David |d 1977- |e VerfasserIn |0 (DE-588)128868104 |0 (DE-627)383668581 |0 (DE-576)297371797 |4 aut | |
| 700 | 1 | |a Schlemmer, Heinz-Peter |d 1961- |e VerfasserIn |0 (DE-588)1025559967 |0 (DE-627)722927142 |0 (DE-576)17334805X |4 aut | |
| 700 | 1 | |a Röthke, Matthias C. |d 1973- |e VerfasserIn |0 (DE-588)129801615 |0 (DE-627)480699364 |0 (DE-576)188708804 |4 aut | |
| 700 | 1 | |a Wolf, Maya Barbara |d 1977- |e VerfasserIn |0 (DE-588)1014136911 |0 (DE-627)705172376 |0 (DE-576)348132565 |4 aut | |
| 700 | 1 | |a Pahernik, Sascha |d 1968- |e VerfasserIn |0 (DE-588)122063163 |0 (DE-627)081713495 |0 (DE-576)293073147 |4 aut | |
| 700 | 1 | |a Chin, Joseph L. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BJU international |d Oxford : Wiley-Blackwell, 1999 |g 127(2021), 5, Seite 544-552 |h Online-Ressource |w (DE-627)320599426 |w (DE-600)2019983-1 |w (DE-576)091140862 |x 1464-410X |7 nnas |a Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer 3-year outcomes of a prospective Phase I study |
| 773 | 1 | 8 | |g volume:127 |g year:2021 |g number:5 |g pages:544-552 |g extent:9 |a Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer 3-year outcomes of a prospective Phase I study |
| 856 | 4 | 0 | |u https://doi.org/10.1111/bju.15268 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bju.15268 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240729 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 122063163 |a Pahernik, Sascha |m 122063163:Pahernik, Sascha |d 50000 |e 50000PP122063163 |k 0/50000/ |p 14 | ||
| 998 | |g 1014136911 |a Wolf, Maya Barbara |m 1014136911:Wolf, Maya Barbara |d 910000 |e 910000PW1014136911 |k 0/910000/ |p 13 | ||
| 998 | |g 129801615 |a Röthke, Matthias C. |m 129801615:Röthke, Matthias C. |p 12 | ||
| 998 | |g 1025559967 |a Schlemmer, Heinz-Peter |m 1025559967:Schlemmer, Heinz-Peter |d 50000 |e 50000PS1025559967 |k 0/50000/ |p 11 | ||
| 998 | |g 128868104 |a Bonekamp, David |m 128868104:Bonekamp, David |d 50000 |e 50000PB128868104 |k 0/50000/ |p 10 | ||
| 998 | |g 132495139 |a Hatiboglu, Gencay |m 132495139:Hatiboglu, Gencay |d 910000 |d 910200 |d 50000 |e 910000PH132495139 |e 910200PH132495139 |e 50000PH132495139 |k 0/910000/ |k 1/910000/910200/ |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1896849024 |e 4559997233 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"noteIll":"Illustrationen","extent":"9 S."}],"name":{"displayForm":["Shiva M. Nair, Gencay Hatiboglu, James Relle, Khalil Hetou, Jason Hafron, Christopher Harle, Zahra Kassam, Robert Staruch, Mathieu Burtnyk, David Bonekamp, Heinz-Peter Schlemmer, Matthias C. Roethke, Maya Mueller-Wolf, Sascha Pahernik and Joseph L. Chin"]},"recId":"1896849024","relHost":[{"part":{"volume":"127","extent":"9","pages":"544-552","year":"2021","text":"127(2021), 5, Seite 544-552","issue":"5"},"language":["eng"],"id":{"zdb":["2019983-1"],"issn":["1464-410X"],"doi":["10.1111/(ISSN)1464-410X"],"eki":["320599426"]},"recId":"320599426","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer 3-year outcomes of a prospective Phase I studyBJU international","title":[{"title_sort":"BJU international","subtitle":"the journal of the British Association of Urological Surgeons, the European Society of Paediatric Urology and the Societé Internationale d'Urologie","title":"BJU international"}],"pubHistory":["83.1999 -"],"origin":[{"publisherPlace":"Oxford ; Oxford ; Oxford [u.a.]","dateIssuedDisp":"1999-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedKey":"1999"}],"note":["Gesehen am 14.03.25"]}],"id":{"doi":["10.1111/bju.15268"],"eki":["1896849024"]},"title":[{"subtitle":"3-year outcomes of a prospective Phase I study","title_sort":"Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer","title":"Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer"}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"note":["Online veröffentlicht: 9. Oktober 2021","Gesehen am 29.07.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"titleAlt":[{"title":"MRI-guided transurethral ultrasound ablation in patients with localised prostate cancer"}],"person":[{"display":"Nair, Shiva","family":"Nair","given":"Shiva","role":"aut"},{"given":"Gencay","role":"aut","family":"Hatiboglu","display":"Hatiboglu, Gencay"},{"given":"James","role":"aut","family":"Relle","display":"Relle, James"},{"role":"aut","given":"Khalil","display":"Hetou, Khalil","family":"Hetou"},{"given":"Jason","role":"aut","display":"Hafron, Jason","family":"Hafron"},{"family":"Harle","display":"Harle, Christopher","given":"Christopher","role":"aut"},{"role":"aut","given":"Zahra","family":"Kassam","display":"Kassam, Zahra"},{"display":"Staruch, Robert","family":"Staruch","role":"aut","given":"Robert"},{"display":"Burtnyk, Mathieu","family":"Burtnyk","given":"Mathieu","role":"aut"},{"display":"Bonekamp, David","family":"Bonekamp","given":"David","role":"aut"},{"family":"Schlemmer","display":"Schlemmer, Heinz-Peter","given":"Heinz-Peter","role":"aut"},{"family":"Röthke","display":"Röthke, Matthias C.","role":"aut","given":"Matthias C."},{"display":"Wolf, Maya Barbara","family":"Wolf","role":"aut","given":"Maya Barbara"},{"display":"Pahernik, Sascha","family":"Pahernik","role":"aut","given":"Sascha"},{"given":"Joseph L.","role":"aut","family":"Chin","display":"Chin, Joseph L."}]} | ||
| SRT | |a NAIRSHIVAHMAGNETICRE2021 | ||